Cholesterol-controlling drug Praluent's not a college education, but with a potential lifelong dosage requirement, the new drug could easily cost as much or more. So consumers with high cholesterol may have thought they had cause to cheer Friday's news that Praluent-approved by the U.S. Food and Drug Administration just this summer-would be covered by health-care industry giant UnitedHealth Group Inc. But while all men may be created equal, not everyone with high-cholesterol-or their insurance plan -- is.